Phase 1 study of TAS-102 administered once daily on a 5-day-per-week schedule in patients with solid tumors - Concepedia

Concepedia

Publication | Closed Access

Phase 1 study of TAS-102 administered once daily on a 5-day-per-week schedule in patients with solid tumors

78

Citations

14

References

2008

Year

Michael J. Overman, Gauri Varadhachary, Scott Kopetz, Melanie B. Thomas, Masakazu Fukushima, Keizo Kuwata, Akira Mita, Robert A. Wolff, Paulo M. Hoff, Henry Xiong,

Investigational New Drugs

5-Day-per-week ScheduleSolid TumorsMedicineCancer ManagementPharmacotherapyCancer TreatmentOncologyRadiation OncologyPhase 1Cancer ResearchRadiologyHealth Sciences

References

	Year	Citations

Page 1

Page 1